Based on the preclinical findings of the role of GDF-15 in cancer cachexia and tumour immunity, early-phase clinical trials have explored GDF-15 inhibition to manage cancer cachexia and enhance immunotherapy efficacy, demonstrating promising results (Figure 2). Here, GDF15 is linked to cancer.